Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tivic Health Systems (TIVC) Research & Development (2021 - 2025)

Tivic Health Systems (TIVC) has 5 years of Research & Development data on record, last reported at $858000.0 in Q3 2025.

  • For Q3 2025, Research & Development rose 103.32% year-over-year to $858000.0; the TTM value through Sep 2025 reached $2.2 million, up 62.76%, while the annual FY2024 figure was $1.3 million, 20.66% down from the prior year.
  • Research & Development reached $858000.0 in Q3 2025 per TIVC's latest filing, up from $655000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $858000.0 in Q3 2025 and bottomed at $175000.0 in Q3 2021.
  • Average Research & Development over 5 years is $390842.1, with a median of $360000.0 recorded in 2023.
  • Peak YoY movement for Research & Development: soared 158.85% in 2022, then plummeted 47.76% in 2024.
  • A 5-year view of Research & Development shows it stood at $313000.0 in 2021, then surged by 38.98% to $435000.0 in 2022, then decreased by 17.24% to $360000.0 in 2023, then fell by 7.5% to $333000.0 in 2024, then soared by 157.66% to $858000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $858000.0 in Q3 2025, $655000.0 in Q2 2025, and $335000.0 in Q1 2025.